Monday, March 18, 2013
People vs. Things
People vs Things
If you’re reading this you most likely know many facts about Cystic Fibrosis. You know that at any given time there are 30,000 children and young adults in the U.S. living with this as yet incurable decease. You know that in 1980 the life expectancy of a person with CF was 14 years, in 1990 - 18 years, in 2009 -35 years and today that number is into the late 30’s. This giant leap in life expectancy for CF patients is a direct result of the CF Foundations activities. Their award winning business model has gained more than anyone could have expected in the area of scientific research for finding a cure for CF. Through the years the foundations effort has methodically added years to patients’ lives with the development of treatments and medications. Just recently break through medications have been developed and are in trial that dramatically effect some CF patient in a positive way and the scientific method of reaching the goal of finding a cure is well planned for several years to come.
Dr. Richard Simon, Internal Medicine and Pulmonary Disease at The University of Michigan has been with CF for 37 years. At a recent CF function he said this “When I first started working with CF I knew there was a light at the end of the tunnel, I just couldn’t see it. Now I can”. This statement implies that one of the best CF Doctors in the world believes that a cure will one day be found for CF. Will it happen in my life time or yours? No one can say for sure, but before it can happen, we must believe it will and work toward that end.
SalsPals Believes!!
WE WILL:
Never surrender.
Climb as high as we need, not wait for the mountain.
Work harder on ourselves than on our task.
Do this together.
What will history say about us?
Will it be “What were these people doing?
OR
How did they do what they did?
Let’s work as hard as we can to reach the light at the end of the tunnel so people ask “How did they do it”.
Until There's a Cure,
Terry Jiannuzzi
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment